v3.20.1
Condensed Consolidated Statements of Operations - USD ($)
3 Months Ended
Dec. 31, 2019
Dec. 31, 2018
OPERATING EXPENSES    
General and administrative expenses $ 2,554,680 $ 422,010
Research and development expenses 1,227,686 4,876
Research and development expense- licenses acquired 0 1,046,965
TOTAL OPERATING EXPENSES 3,782,366 1,473,851
LOSS FROM OPERATIONS (3,782,366) (1,473,851)
OTHER EXPENSE    
Interest expense (1,311) (14,637)
Change in fair value of warrant liabilities (694,134) 0
Loss on disposal of fixed asset (3,230) 0
Equity in losses on equity method investment (24,509) 0
Total other expenses   (14,637)
Total other expense, net (723,184) (14,637)
NET LOSS $ (4,505,550) $ (1,488,488)
BASIC AND DILUTED LOSS PER SHARE (in dollars per share) $ (0.26) $ (0.25)
WEIGHTED AVERAGE SHARES OUTSTANDING:    
BASIC AND DILUTED 17,071,678 5,863,333

Source